Should I buy or sell Tabula Rasa HealthCare stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TRHC shares. View TRHC analyst ratings or view top-rated stocks .

What is Tabula Rasa HealthCare's stock price target for 2024?

4 Wall Street research analysts have issued twelve-month price targets for Tabula Rasa HealthCare's stock. Their TRHC share price targets range from $10.00 to $10.00. On average, they expect the company's stock price to reach $10.00 in the next year. This suggests that the stock has a possible downside of 4.8%. View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts .

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) announced its quarterly earnings results on Thursday, November, 4th. The company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.15. The business earned $86.60 million during the quarter, compared to analysts' expectations of $88.54 million. The company's revenue was up 22.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.35) EPS.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com . Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA) , Advanced Micro Devices (AMD) , QUALCOMM (QCOM) , Adobe (ADBE) , Micron Technology (MU) , Boeing (BA) , Salesforce (CRM) , Intel (INTC) and Netflix (NFLX) .

When did Tabula Rasa HealthCare IPO?

Tabula Rasa HealthCare (TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

NASDAQ:TRHC

Tabula Rasa HealthCare (TRHC) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free TRHC Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.50
▼
$10.50
50-Day Range: $10.37
▼
$10.50
52-Week Range: $3.15
▼
$10.50

Volume: N/A
Average Volume: 225,500 shs
Market Capitalization: $284.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.00

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Social Media

Get Tabula Rasa HealthCare alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Tabula Rasa HealthCare Stock (NASDAQ:TRHC)

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

Click here to find out that this 8,788% cryptocurrency is.

TRHC Stock News Headlines

March 2, 2024 | benzinga.com

Daniel C Lubin's Net Worth

February 8, 2024 | msn.com

Leeds city centre bars Below Stairs and Tabula Rasa 'thrilled' to be named in UK's Top 50 Cocktail Bars

April 18, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

October 31, 2023 | msn.com

Tabula Rasa HealthCare gets stockholder nod for going-private transaction

October 31, 2023 | finance.yahoo.com

Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners

September 20, 2023 | finance.yahoo.com

With 46% ownership, Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has piqued the interest of institutional investors

September 6, 2023 | thestreet.com

Tabula Rasa HealthCare Inc. News

August 31, 2023 | msn.com

Tabula Rasa HealthCare (TRHC) Price Target Increased by 23.38% to 10.54

April 18, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

August 8, 2023 | markets.businessinsider.com

Stifel Nicolaus Sticks to Their Hold Rating for Tabula Rasa HealthCare (TRHC)

August 8, 2023 | msn.com

William Blair Downgrades Tabula Rasa HealthCare (TRHC)

August 8, 2023 | markets.businessinsider.com

Piper Sandler Reaffirms Their Hold Rating on Tabula Rasa HealthCare (TRHC)

August 8, 2023 | markets.businessinsider.com

Why Are Tabula Rasa HealthCare Shares Moving Higher Today?

August 8, 2023 | finance.yahoo.com

Tabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass Estimates

August 8, 2023 | finance.yahoo.com

Compared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key Metrics

August 8, 2023 | finance.yahoo.com

Tabula Rasa agrees to be acquired in $570M all-cash deal, less than a year after pushing out its founder

August 8, 2023 | finance.yahoo.com

Why Shares of Tabula Rasa HealthCare Are Soaring Monday

August 7, 2023 | finanznachrichten.de

Tabula Rasa HealthCare, Inc.: Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

August 7, 2023 | seekingalpha.com

Tabula Rasa going private; will merge with ExactCare Pharmacy

August 7, 2023 | marketwatch.com

Tabula Rasa Shares Rally Premarket on Private-Equity Buyout

August 7, 2023 | markets.businessinsider.com

Tabula Rasa To Go Private In $570 Mln Deal With Nautic Partners; Stock Up In Premarket

August 7, 2023 | marketwatch.com

Nautic Partners to Buy Tabula Rasa HealthCare in $570 Million Deal >TRHC

August 7, 2023 | finance.yahoo.com

Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs

August 7, 2023 | finance.yahoo.com

Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

August 4, 2023 | benzinga.com

Earnings Outlook For Tabula Rasa HealthCare

July 25, 2023 | finance.yahoo.com

Tabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference Call

June 12, 2023 | finance.yahoo.com

Tabula Rasa Healthcare (TRHC) Surges 7.8%: Is This an Indication of Further Gains?

See More Headlines

Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/04/2021
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: NASDAQ:TRHC
CUSIP: N/A
CIK: 1651561
Web: www.tabularasahealthcare.com
Phone: (866) 648-2767
Fax: N/A
Employees: 1,027
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $10.00
High Stock Price Target: $10.00
Low Stock Price Target: $10.00
Potential Upside/Downside: -4.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.85)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-147,510,000.00
Net Margins: -28.23%
Pretax Margin: -17.99%
Return on Equity: N/A
Return on Assets: -8.80%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.57
Quick Ratio: 1.47

Sales & Book Value

Annual Sales: $299.52 million
Price / Sales: 0.95
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($2.10) per share
Price / Book: -5.00

Miscellaneous

Outstanding Shares: 27,060,000
Free Float: 18,857,000
Market Cap: $284.13 million
Optionable: Optionable
Beta: 1.57

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Brian W. Adams (Age 41)
CEO, President & Director
Comp: $668.21k
Mr. Thomas J. Cancro C.F.A. (Age 55)
CPA, Chief Financial Officer
Comp: $523.42k
Mr. Michael Greenhalgh BScPharm (Age 61)
RPh, COO & President of Pharmacy Services
Comp: $630.9k
Mr. Michael Bruno (Age 35)
VP, Corporate Controller & Chief Accounting Officer
Mr. Bob Sullivan M.S.
Chief Technology Officer
Mr. Phillip W. Heath MS (Age 57)
Chief Administrative Officer
Mr. Frank Sparacino C.F.A.
CPA, Senior Vice President of Investor Relations & Corporate Development
Mr. Richard W. Rew II (Age 55)
Chief Legal Officer & Corporate Secretary
Ms. Kathleen D Larkin M.B.A.
Chief People Officer
Ms. Andrea Carolan Speers M.S. (Age 42)
Chief of Staff

Key Competitors

View All Competitors

Institutional Ownership

Simplex Trading LLC
Sold 2,200 shares on 2/2/2024
Ownership: 0.000%

View All Institutional Transactions

TRHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Tabula Rasa HealthCare stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TRHC shares.
View TRHC analyst ratings or view top-rated stocks.
What is Tabula Rasa HealthCare's stock price target for 2024?: 4 Wall Street research analysts have issued twelve-month price targets for Tabula Rasa HealthCare's stock. Their TRHC share price targets range from $10.00 to $10.00. On average, they expect the company's stock price to reach $10.00 in the next year. This suggests that the stock has a possible downside of 4.8%.
View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts.
How were Tabula Rasa HealthCare's earnings last quarter?: Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) announced its quarterly earnings results on Thursday, November, 4th. The company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.15. The business earned $86.60 million during the quarter, compared to analysts' expectations of $88.54 million. The company's revenue was up 22.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.35) EPS.
What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?: 24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).
When did Tabula Rasa HealthCare IPO?: Tabula Rasa HealthCare (TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

This page (NASDAQ:TRHC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tabula Rasa HealthCare (TRHC) Stock Price, News & Analysis

About Tabula Rasa HealthCare Stock (NASDAQ:TRHC)

TRHC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

TRHC Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info